Can a supplement boost diabetes drug effects? new study launches.
NCT ID NCT07195994
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a supplement called AMPK Charge+® can help control blood sugar in adults with prediabetes or type 2 diabetes, both on its own and when combined with the drug semaglutide. About 90 participants will take the supplement daily, with some also receiving semaglutide injections. Researchers will measure changes in fasting blood sugar, insulin, and HbA1c over 84 days to see which approach works better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREDIABETES / TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
KGK Science Inc.
RECRUITINGLondon, Ontario, N6B3L1, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tiny blood particles may hold early clues to type 2 diabetes risk in obesity
- Dentist visit could catch hidden diabetes risk
- HIIT vs steady exercise: which works better for prediabetes?
- Rice to the rescue: new study tests Low-GI, High-Protein rice for diabetes prevention
- Patch pump vs. shots: can a smart insulin device tame Steroid-Related blood sugar spikes?
- Can daily stress predict diabetes? new study targets hispanic community